Navin Varadarajan, Ph.D.
Affiliations: | 2007 | Chemistry | University of Texas at Austin, Austin, Texas, U.S.A. |
Area:
Antibody and Enzyme EngineeringGoogle:
"Navin Varadarajan"Mean distance: 8.61 | S | N | B | C | P |
Parents
Sign in to add mentor| Brent L. Iverson | grad student | 2007 | UT Austin | |
| (Engineering highly active and specific protease variants.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Montalvo MJ, Bandey IN, Rezvan A, et al. (2024) Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition. Cell Death & Disease. 15: 109 |
| Romain G, Strati P, Rezvan A, et al. (2022) Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. The Journal of Clinical Investigation |
| Bandey IN, Adolacion JRT, Romain G, et al. (2021) Designed improvement to T-cell immunotherapy by multidimensional single cell profiling. Journal For Immunotherapy of Cancer. 9 |
| Rath JA, Bajwa G, Carreres B, et al. (2020) Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 T cells. Science Advances. 6: eaaz7809 |
| Daher M, Basar R, Gokdemir E, et al. (2020) Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood |
| Doshi A, Sadeghi F, Varadarajan N, et al. (2020) Small-molecule inducible transcriptional control in mammalian cells. Critical Reviews in Biotechnology. 1-20 |
| Fousek K, Watanabe J, Joseph SK, et al. (2020) CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia |
| Ramesh B, Abnouf S, Mali S, et al. (2019) Engineered ChymotrypsiN for Mass Spectrometry-Based Detection of Protein Glycosylation. Acs Chemical Biology |
| Liadi I, Singh H, Romain G, et al. (2019) Defining potency of CAR T cells: Fast and furious or slow and steady. Oncoimmunology. 8: e1051298 |
| An X, Adolacion JR, Alfayez M, et al. (2019) Single-Cell Deconvolution Identifies T-Cell Correlates of Response to PD-1 Blockade Treatment in AML Blood. 134: 1950-1950 |